Ocugen to Host Conference Call on Tuesday, November 9 at 8:30 a.m. ET to Discuss Third Quarter 2021 Financial Results and Provide Business Update
Ocugen will issue a pre-market earnings announcement on the same day. Investors are invited to participate on the call using the following details:Dial-In Number: (844) 873-7330 (U.S.) or (602) 563-8473 (international)Conference ID: 8198297Webcast: Available in the “Investors” section of the Ocugen website and archived for approximately 45 days following the call
Financial Analyst
OP
:
Look at their balance sheet, assets is growing every quarter. Expected to grow with similar trend. Moreover, with the WHO approval they might even expand the pipeline (currently US & Canada) to other countries. There’s a reason why whales are shorting this and bringing down the price, I would suggest to wait for the coming announcement, you might find surprises.
PlaceYourBets : is the company making money?
vnguyen95 : Any hopes to go up?
313yang vnguyen95 : No matter how bad this year is, it will be better than last year. We should have had a chance
313yang Financial Analyst OP :
Financial Analyst OP : Look at their balance sheet, assets is growing every quarter. Expected to grow with similar trend. Moreover, with the WHO approval they might even expand the pipeline (currently US & Canada) to other countries. There’s a reason why whales are shorting this and bringing down the price, I would suggest to wait for the coming announcement, you might find surprises.
Mikey_Vibez : Waiting to see the latest quarterly earnings report of OCGN
student otg Financial Analyst OP : are you invested here as well at $Biora Therapeutics (PROG.US)$